Recruiting NA Rectal Cancer

New treatment option for Rectal Cancer

Official title Developing and Testing the Effect of Online Interactive Videos in Improving Low Anterior Resection Syndrome.

ClinicalTrials.gov ID: NCT06628674

What this study is testing

What it's testing
This study aims to develop and test the effect of online interactive videos in improving LARS.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 20 and older

You may be able to join if

  • Stage I-III rectal cancer.
  • Patients already know their condition.
  • Aged 20 years and older.
  • Consciously communicate in Mandarin or Taiwanese.
  • Agreed with the interview and had signed the permit.

You likely can't join if

  • Recurrent rectal cancer.
  • Stage IV rectal cancer.

The study team makes the final eligibility decision.

Where it's taking place

  • Taoyuan, 中和區, Taiwan

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 20 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Taoyuan, 中和區, Taiwan. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.